Literature DB >> 16147855

GLUT1 is highly expressed in cementoblasts but not in osteoblasts.

Hirofumi Koike1, Katsuhiro Uzawa, Wojciech J Grzesik, Naohiko Seki, Yosuke Endo, Atsushi Kasamatsu, Mitsuo Yamauchi, Hideki Tanzawa.   

Abstract

Cementum is a specialized mineralized tissue covering root surface of the tooth. Although the tissue's composition resembles bone, there are distinct structural and functional differences between the two mineralized tissues. In this study, the genes that are differentially expressed in putative cementoblasts (human cementum-derived cells [HCDCs]) compared with preosteoblastic cells (human bone marrow stromal cells [BMSCs]) were screened by two independent microarray systems, and some of the selected genes were further analyzed by quantitative real-time RT-PCR. The gene encoding glucose transporter 1 [GLUT1], which showed the greatest difference between the two groups by the latter analysis, was subjected to further analyses. High levels of the GLUT1 protein in HCDCs, but not in BMSCs, were detected by Western blotting and immunocytochemistry. Furthermore, intense immunoreactivities for GLUT1 were observed in cementoblasts and cementocytes but not in osteoblasts or osteocytes in human periodontal tissues. These results indicate that GLUT1 may play a role in cementogenesis and could serve as a biomarker to differentiate between cells of cementoblastic and osteoblastic lineage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16147855     DOI: 10.1080/03008200591008437

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  5 in total

1.  Gene-expression analysis of cementoblasts and osteoblasts.

Authors:  B G Matthews; H Roguljic; T Franceschetti; E Roeder; I Matic; I Vidovic; P Joshi; K-Y Kum; I Kalajzic
Journal:  J Periodontal Res       Date:  2015-07-27       Impact factor: 4.419

2.  Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.

Authors:  Toshihiro Shimizu; Atsushi Kasamatsu; Ayumi Yamamoto; Kazuyuki Koike; Shunsaku Ishige; Hiroaki Takatori; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

3.  Kinesin family member 4A: a potential predictor for progression of human oral cancer.

Authors:  Yasuyuki Minakawa; Atsushi Kasamatsu; Hirofumi Koike; Morihiro Higo; Dai Nakashima; Yukinao Kouzu; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

4.  Adenosine A2b receptor promotes progression of human oral cancer.

Authors:  Hiroki Kasama; Yosuke Sakamoto; Atsushi Kasamatsu; Atsushi Okamoto; Tomoyoshi Koyama; Yasuyuki Minakawa; Katsunori Ogawara; Hidetaka Yokoe; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  BMC Cancer       Date:  2015-07-31       Impact factor: 4.430

5.  Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.

Authors:  Atsushi Okamoto; Morihiro Higo; Masashi Shiiba; Dai Nakashima; Tomoyoshi Koyama; Isao Miyamoto; Hiroki Kasama; Atsushi Kasamatsu; Katsunori Ogawara; Hidetaka Yokoe; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.